Nintedanib (Prutis): Antifibrotic Therapy for Pulmonary Fibrosis & ILDs

Prutis (Nintedanib) Soft Gelatin Capsules are antifibrotic drugs used in IPF treatment, ILD treatment, and SSc-ILD management. Available as nintedanib 150 mg and nintedanib 100 mg, this lung fibrosis medicine helps slow disease progression and preserve lung function. Nintedanib works by blocking multiple tyrosine kinases involved in fibrotic pathways, thereby reducing scar tissue formation in the lungs. Nintedanib uses include managing pulmonary fibrosis symptoms such as breathlessness and persistent cough. Common nintedanib side effects may include diarrhea, nausea, and liver enzyme elevation. Nintedanib gelatin capsules should be taken under medical supervision for safe and effective long-term therapy.